Maryia Zarechyntsava

Maryia Zarechyntsava

Auto-generated profile, based on publicly available information

Maryia Zarechyntsava

Malopolska Centre of Biotechnology, Jagiellonian University, Krakow 30-387, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2024 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
VZViacheslav Zemlianski
Viacheslav Zemlianski
AMAnna Marešová
Anna Marešová
JPJarmila Princová
Jarmila Princová
RHRoman Holič
Roman Holič
RHRobert Häsler
Robert Häsler
MPMartin Převorovský
Martin Převorovský
Mitosis is a crucial stage in the cell cycle, controlled by a vast network of regulators responding to multiple internal and external factors. The fission yeast Schizosaccharomyces pombe demonstrates catastrophic mitotic phenotypes due to mutations or drug treatments. One of the factors provoking catastrophic mitosis is a disturbed lipid metabolism, resulting from, for example, mutations in the acetyl-CoA/biotin carboxylase (cut6), fatty acid synthase (fas2, also known as lsd1) or transcriptional regulator of lipid metabolism (cbf11) genes, as well as treatment with inhibitors of fatty acid synthesis. It has been previously shown that mitotic fidelity in lipid metabolism mutants can be partially rescued by ammonium chloride supplementation. In this study, we demonstrate that mitotic fidelity can be improved by multiple nitrogen sources. Moreover, this improvement is not limited to lipid metabolism disturbances but also applies to a number of unrelated mitotic mutants. Interestingly, the partial rescue is not achieved by restoring the lipid metabolism state, but rather indirectly. Our results highlight a novel role for nitrogen availability in mitotic fidelity.

8 October 2025 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
AGAgnieszka Gawin
Agnieszka Gawin
JPJedrzej Pankowski
Jedrzej Pankowski
MZMaria Zarechyntsava
Maria Zarechyntsava
DKDominika Kwasna
Dominika Kwasna
DKDamian Kloska
Damian Kloska
YAYusuke Azuma
Yusuke Azuma
Engineered protein cages protect cargo from cellular proteases and release it outside the cell. This system enables the efficient microbial production of therapeutic peptides that are otherwise susceptible to degradation.

8 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAgnieszka Gawin
Agnieszka Gawin
JPJęDrzej Pankowski
JęDrzej Pankowski
MZMaria Zarechyntsava
Maria Zarechyntsava
DKDominika Kwasna
Dominika Kwasna
DKDamian Kloska
Damian Kloska
YAYusuke Azuma
Yusuke Azuma
Degradation during production and delivery is a significant bottleneck in developing biomolecular therapies. Here, we show that encapsulation in protein cages formed by engineered variants of a cage-forming lumazine synthase establishes an effective route for microbial production and isolation of otherwise difficult-to-express, degradation-prone polypeptides. In this system, genetic fusion to a cage component protomer ensures efficient guest packaging while being produced in host bacterial cells. Meanwhile, the controlled opening outside the cellular context allows facile isolation of cargo via sequence-specific protease cleavage. Furthermore, modular patchwork assembly avoids guest overloading, preventing unwanted incomplete cage assembly and the formation of insoluble aggregates. The general applicability of our “encapsidic” production approach was demonstrated by the efficient production of six intrinsically disordered polypeptides that have proven therapeutic potentials.

27 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
VZViacheslav Zemlianski
Viacheslav Zemlianski
AMAnna Marešová
Anna Marešová
JPJarmila Princová
Jarmila Princová
RHRoman Holič
Roman Holič
RHRobert Häsler
Robert Häsler
MPMartin Převorovský
Martin Převorovský
Mitosis is a critical stage in the cell cycle, controlled by a vast network of regulators responding to multiple internal and external factors. The fission yeast Schizosaccharomyces pombe may demonstrate catastrophic mitotic phenotypes due to mutations or drug treatments. One of the factors provoking catastrophic mitosis is a disturbed lipid metabolism, resulting from e.g. mutations in acetyl-CoA/biotin carboxylase ( cut6 ), in fatty acid synthase ( fas2/lsd1 ), or in the transcriptional regulator of lipid metabolism ( cbf11 ) genes, as well as treatment with inhibitors of fatty acid synthesis. It was previously shown that mitotic fidelity in lipid metabolism mutants can be partially rescued by ammonium chloride. In this study we demonstrate that mitotic fidelity can be improved by multiple good nitrogen sources. Moreover, this rescue is not limited to lipid metabolism disturbances but also applies to a number of unrelated mitotic mutants. Interestingly, the rescue is not achieved by restoring the lipid metabolism state, but rather indirectly. We found that the TOR regulatory network plays a major role in mediating such rescue, highlighting a novel role for TOR in mitotic fidelity.